United States Pharmaceuticals

Teligent Inc (NEW JERSEY) (TLGT)

Track

Ticker: TLGT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Pate R Carter
1 purchase — total 16,491 USD
Buy 27 May 2021
Value US$222,341.98 | Price 110.87 | Shares 97,030
Sale 26 Aug 2020
Value US$2,841,840.19 | Price 337.30 | Shares 72,319
Sale 26 Aug 2020
Value US$2,700,504.81 | Price 291.66 | Shares 28,731
Sale 25 Aug 2020
Value US$17,106.29 | Price 1.13 | Shares 15,184
Sale 25 Aug 2020
Value US$96,147.42 | Price 1.13 | Shares 84,816
Sale 21 Aug 2020
Value US$30,539.98 | Price 1.66 | Shares 18,432
Sale 21 Aug 2020
Value US$171,071.36 | Price 1.66 | Shares 102,962
Sale 19 Aug 2020
Value US$29,760.42 | Price 2.25 | Shares 13,251
Sale 19 Aug 2020
Value US$167,026.13 | Price 2.26 | Shares 74,020
Buy 3 Jun 2019
Value US$7,005.00 | Price 0.70 | Shares 10,000
Buy 31 May 2019
Value US$16,520.00 | Price 0.66 | Shares 25,000
Buy 31 May 2019
Value US$12,904.00 | Price 0.65 | Shares 20,000
Buy 31 May 2019
Value US$13,166.00 | Price 0.66 | Shares 20,000
Buy 30 May 2019
Value US$5,885.00 | Price 0.59 | Shares 10,000
Buy 23 May 2019
Value US$17,335.00 | Price 0.69 | Shares 25,000
Buy 23 May 2019
Value US$13,814.00 | Price 0.69 | Shares 20,000
Buy 14 Dec 2018
Value US$18,200.00 | Price 1.82 | Shares 10,000
Buy 14 Dec 2018
Value US$21,372.00 | Price 1.78 | Shares 12,000
Planned sale 4 Sep 2018
Value US$400.50 | Price 4.01 | Shares 100
Planned sale 4 Sep 2018
Value US$210,800.00 | Price 4.00 | Shares 52,700
Buy 13 Nov 2017
Value US$12,538.80 | Price 3.48 | Shares 3,600
Buy 13 Nov 2017
Value US$4,869.76 | Price 3.48 | Shares 1,400
Buy 10 Nov 2017
Value US$1,084.02 | Price 3.61 | Shares 300
Buy 10 Nov 2017
Value US$10,490.46 | Price 3.62 | Shares 2,900
Buy 10 Nov 2017
Value US$6,513.84 | Price 3.62 | Shares 1,800
Buy 10 Nov 2017
Value US$57,136.50 | Price 3.81 | Shares 15,000
Buy 9 Nov 2017
Value US$20,055.61 | Price 3.13 | Shares 6,410
Buy 8 Nov 2017
Value US$21,280.00 | Price 3.04 | Shares 7,000
Buy 11 Mar 2016
Value US$73,717.50 | Price 4.91 | Shares 15,000
Buy 11 Mar 2016
Value US$50,628.90 | Price 4.82 | Shares 10,500
Buy 30 Apr 2015
Value US$50,400.00 | Price 5.04 | Shares 10,000
Buy 30 Apr 2015
Value US$100,800.00 | Price 5.04 | Shares 20,000
Sale 5 Mar 2015
Value US$16,878,384.00 | Price 9.95 | Shares 1,696,320
Sale 5 Mar 2015
Value US$3,021,616.00 | Price 9.95 | Shares 303,680
Sale 2 Sep 2014
Value US$10,942,425.00 | Price 6.45 | Shares 1,696,500
Sale 2 Sep 2014
Value US$1,957,575.00 | Price 6.45 | Shares 303,500
Sale 27 Aug 2014
Value US$15,777,406.60 | Price 6.20 | Shares 2,544,743
Sale 27 Aug 2014
Value US$2,822,593.40 | Price 6.20 | Shares 455,257
Buy 22 Aug 2014
Value US$29,500.00 | Price 5.90 | Shares 5,000
Sale 9 Jun 2014
Value US$95,900.00 | Price 5.48 | Shares 17,500
Buy 6 Aug 2013
Value US$17,304.32 | Price 1.45 | Shares 11,902
Buy 5 Aug 2013
Value US$5,919.20 | Price 1.48 | Shares 4,000
Buy 2 Aug 2013
Value US$14,794.00 | Price 1.48 | Shares 10,000
Buy 30 Jul 2013
Value US$6,671.84 | Price 1.48 | Shares 4,508
Buy 26 Jul 2013
Value US$29,189.10 | Price 1.49 | Shares 19,590
Buy 24 May 2013
Value US$5,425.00 | Price 1.55 | Shares 3,500
Buy 13 Mar 2013
Value US$13,265.00 | Price 1.33 | Shares 10,000
Buy 13 Mar 2013
Value US$6,647.00 | Price 1.33 | Shares 5,000
Buy 12 Mar 2013
Value US$2,814.00 | Price 1.34 | Shares 2,100
Buy 12 Mar 2013
Value US$1,201.50 | Price 1.34 | Shares 900
Buy 12 Mar 2013
Value US$16,280.00 | Price 1.30 | Shares 12,500
Buy 11 Mar 2013
Value US$3,630.00 | Price 1.21 | Shares 3,000
Buy 11 Mar 2013
Value US$552.24 | Price 1.18 | Shares 468
Buy 8 Mar 2013
Value US$1,807.76 | Price 1.18 | Shares 1,532
Buy 7 Mar 2013
Value US$8,784.85 | Price 1.15 | Shares 7,639
Buy 6 Mar 2013
Value US$5,697.72 | Price 1.14 | Shares 4,998
Buy 14 Aug 2012
Value US$11,500.00 | Price 1.15 | Shares 10,000
Sale 23 May 2012
Value US$6,650.00 | Price 0.95 | Shares 7,000
Sale 22 May 2012
Value US$9,500.00 | Price 0.95 | Shares 10,000
Sale 21 May 2012
Value US$907.00 | Price 1.00 | Shares 907
Sale 18 May 2012
Value US$843.00 | Price 1.00 | Shares 843
Sale 17 May 2012
Value US$306.00 | Price 1.02 | Shares 300
Sale 16 May 2012
Value US$608.00 | Price 1.00 | Shares 608
Sale 15 May 2012
Value US$1,485.00 | Price 1.00 | Shares 1,485
Sale 11 May 2012
Value US$15.75 | Price 1.05 | Shares 15
Sale 19 Mar 2012
Value US$9,775.00 | Price 1.15 | Shares 8,500
Sale 1 Mar 2012
Value US$5,600.50 | Price 1.15 | Shares 4,870
Sale 28 Feb 2012
Value US$149.50 | Price 1.15 | Shares 130
Sale 11 May 2011
Value US$29,750.00 | Price 1.19 | Shares 25,000
Sale 27 Jan 2011
Value US$8,750.00 | Price 1.75 | Shares 5,000
Sale 16 Nov 2010
Value US$8,000.00 | Price 1.60 | Shares 5,000
Buy 10 Aug 2010
Value US$768.00 | Price 1.28 | Shares 600
Buy 10 Aug 2010
Value US$650.00 | Price 1.30 | Shares 500
Buy 9 Aug 2010
Value US$1,210.00 | Price 1.21 | Shares 1,000
Buy 9 Aug 2010
Value US$248.00 | Price 1.24 | Shares 200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-27 2021-05-27 B Purchase
3.0
Pate R Carter
Non-Executive Director
97,030 -2.6%
110.87
US$222,342 		97,030 -2.6% 110.87 US$222,342
2020-09-16 2020-08-26 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
72,319 +46.0%
337.30
US$2,841,840 		72,319 +46.0% 337.30 US$2,841,840
2020-09-16 2020-08-26 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
28,731 -12.0%
291.66
US$2,700,505 		28,731 -12.0% 291.66 US$2,700,505
2020-09-16 2020-08-25 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
15,184 -12.9%
1.13
US$17,106 		15,184 -12.9% 1.13 US$17,106
2020-09-16 2020-08-25 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
84,816 -12.9%
1.13
US$96,147 		84,816 -12.9% 1.13 US$96,147
2020-09-16 2020-08-21 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
18,432 -13.5%
1.66
US$30,540 		18,432 -13.5% 1.66 US$30,540
2020-09-16 2020-08-21 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
102,962 -13.5%
1.66
US$171,071 		102,962 -13.5% 1.66 US$171,071
2020-09-16 2020-08-19 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
13,251 -8.9%
2.25
US$29,760 		13,251 -8.9% 2.25 US$29,760
2020-09-16 2020-08-19 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
74,020 -8.9%
2.26
US$167,026 		74,020 -8.9% 2.26 US$167,026
2019-06-04 2019-06-03 B Purchase
CHAUDHURI BHASKAR
10,000 +inf%
0.70
US$7,005 		10,000 +inf% 0.70 US$7,005
2019-06-03 2019-05-31 B Purchase
SABATINO THOMAS J JR
25,000 +inf%
0.66
US$16,520 		25,000 +inf% 0.66 US$16,520
2019-05-31 2019-05-31 B Purchase
Celentano John E
Non-Executive Director
20,000 +inf%
0.65
US$12,904 		20,000 +inf% 0.65 US$12,904
2019-05-31 2019-05-31 B Purchase
GALE JAMES C
Non-Executive Director
20,000 +5.3%
0.66
US$13,166 		20,000 +5.3% 0.66 US$13,166
2019-05-31 2019-05-30 B Purchase
3.5
BEN-MAIMON CAROLE
10,000 +166.7%
0.59
US$5,885 		10,000 +166.7% 0.59 US$5,885
2019-05-24 2019-05-23 B Purchase
Grenfell-Gardner Jason

President & CEO

Executive Director
25,000 +26.4%
0.69
US$17,335 		25,000 +26.4% 0.69 US$17,335
2019-05-24 2019-05-23 B Purchase
GALE JAMES C
Non-Executive Director
20,000 +5.6%
0.69
US$13,814 		20,000 +5.6% 0.69 US$13,814
2018-12-14 2018-12-14 B Purchase Finio Damian

CFO

Officer
10,000 +inf%
1.82
US$18,200 		10,000 +inf% 1.82 US$18,200
2018-12-14 2018-12-14 B Purchase Richardson Stephen

Chief Scientific Officer

Officer
12,000 +30.6%
1.78
US$21,372 		12,000 +30.6% 1.78 US$21,372
2018-09-05 2018-09-04 PlS Planned sale Grenfell-Gardner Jason

President & CEO

Executive Director
100 -0.1%
4.01
US$400 		100 -0.1% 4.01 US$400
2018-09-05 2018-09-04 PlS Planned sale Grenfell-Gardner Jason

President & CEO

Executive Director
52,700 -35.7%
4.00
US$210,800 		52,700 -35.7% 4.00 US$210,800
2017-11-13 2017-11-13 B Purchase BEN-MAIMON CAROLE
3,600 +150.0%
3.48
US$12,539 		3,600 +150.0% 3.48 US$12,539
2017-11-13 2017-11-13 B Purchase BEN-MAIMON CAROLE
1,400 +140.0%
3.48
US$4,870 		1,400 +140.0% 3.48 US$4,870
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
300 +6.4%
3.61
US$1,084 		300 +6.4% 3.61 US$1,084
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
2,900 +161.1%
3.62
US$10,490 		2,900 +161.1% 3.62 US$10,490
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
1,800 +inf%
3.62
US$6,514 		1,800 +inf% 3.62 US$6,514
2017-11-13 2017-11-10 B Purchase GALE JAMES C
15,000 +4.4%
3.81
US$57,136 		15,000 +4.4% 3.81 US$57,136
2017-11-13 2017-11-09 B Purchase Richardson Stephen

Chief Scientific Officer
6,410 +76.9%
3.13
US$20,056 		6,410 +76.9% 3.13 US$20,056
2017-11-09 2017-11-08 B Purchase Collins Jenniffer

CFO
7,000 +57.3%
3.04
US$21,280 		7,000 +57.3% 3.04 US$21,280
2016-03-14 2016-03-11 B Purchase GALE JAMES C Non-Executive Director Large shareholder
15,000 +150.0%
4.91
US$73,718 		15,000 +150.0% 4.91 US$73,718
2016-03-14 2016-03-11 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
10,500 +4.4%
4.82
US$50,629 		10,500 +4.4% 4.82 US$50,629
2015-05-01 2015-04-30 B Purchase GALE JAMES C Non-Executive Director Large shareholder
10,000 +25.2%
5.04
US$50,400 		10,000 +25.2% 5.04 US$50,400
2015-05-01 2015-04-30 B Purchase GALE JAMES C Non-Executive Director Large shareholder
20,000 +101.9%
5.04
US$100,800 		20,000 +101.9% 5.04 US$100,800
2015-03-06 2015-03-05 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
1,696,320 -16.9%
9.95
US$16,878,384 		1,696,320 -16.9% 9.95 US$16,878,384
2015-03-06 2015-03-05 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
303,680 -16.9%
9.95
US$3,021,616 		303,680 -16.9% 9.95 US$3,021,616
2014-09-04 2014-09-02 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
1,696,500 -14.4%
6.45
US$10,942,425 		1,696,500 -14.4% 6.45 US$10,942,425
2014-09-04 2014-09-02 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
303,500 -14.4%
6.45
US$1,957,575 		303,500 -14.4% 6.45 US$1,957,575
2014-08-29 2014-08-27 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
2,544,743 -17.8%
6.20
US$15,777,407 		2,544,743 -17.8% 6.20 US$15,777,407
2014-08-29 2014-08-27 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
455,257 -17.8%
6.20
US$2,822,593 		455,257 -17.8% 6.20 US$2,822,593
2014-08-26 2014-08-22 B Purchase GALE JAMES C Non-Executive Director Large shareholder
5,000 +34.2%
5.90
US$29,500 		5,000 +34.2% 5.90 US$29,500
2014-06-11 2014-06-09 S Sale Erony Joyce Non-Executive Director
17,500 -76.6%
5.48
US$95,900 		17,500 -76.6% 5.48 US$95,900
2013-08-07 2013-08-06 B Purchase Hemric Michael B. Non-Executive Director
11,902 +19.3%
1.45
US$17,304 		11,902 +19.3% 1.45 US$17,304
2013-08-07 2013-08-05 B Purchase Hemric Michael B. Non-Executive Director
4,000 +6.9%
1.48
US$5,919 		4,000 +6.9% 1.48 US$5,919
2013-08-07 2013-08-02 B Purchase Hemric Michael B. Non-Executive Director
10,000 +21.0%
1.48
US$14,794 		10,000 +21.0% 1.48 US$14,794
2013-08-07 2013-07-30 B Purchase Hemric Michael B. Non-Executive Director
4,508 +10.5%
1.48
US$6,672 		4,508 +10.5% 1.48 US$6,672
2013-08-07 2013-07-26 B Purchase Hemric Michael B. Non-Executive Director
19,590 +83.3%
1.49
US$29,189 		19,590 +83.3% 1.49 US$29,189
2013-05-29 2013-05-24 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
3,500 +35.0%
1.55
US$5,425 		3,500 +35.0% 1.55 US$5,425
2013-03-15 2013-03-13 B Purchase GALE JAMES C Non-Executive Director Large shareholder
10,000 +216.3%
1.33
US$13,265 		10,000 +216.3% 1.33 US$13,265
2013-03-14 2013-03-13 B Purchase Erony Joyce Non-Executive Director Large shareholder
5,000 +28.0%
1.33
US$6,647 		5,000 +28.0% 1.33 US$6,647
2013-03-14 2013-03-12 B Purchase Hemric Michael B. Non-Executive Director
2,100 +9.8%
1.34
US$2,814 		2,100 +9.8% 1.34 US$2,814
2013-03-14 2013-03-12 B Purchase Hemric Michael B. Non-Executive Director
900 +4.4%
1.34
US$1,202 		900 +4.4% 1.34 US$1,202
2013-03-14 2013-03-12 B Purchase Erony Joyce Non-Executive Director Large shareholder
12,500 +233.7%
1.30
US$16,280 		12,500 +233.7% 1.30 US$16,280
2013-03-14 2013-03-11 B Purchase Hemric Michael B. Non-Executive Director
3,000 +17.1%
1.21
US$3,630 		3,000 +17.1% 1.21 US$3,630
2013-03-14 2013-03-11 B Purchase Hemric Michael B. Non-Executive Director
468 +2.7%
1.18
US$552 		468 +2.7% 1.18 US$552
2013-03-14 2013-03-08 B Purchase Hemric Michael B. Non-Executive Director
1,532 +9.9%
1.18
US$1,808 		1,532 +9.9% 1.18 US$1,808
2013-03-14 2013-03-07 B Purchase Hemric Michael B. Non-Executive Director
7,639 +96.9%
1.15
US$8,785 		7,639 +96.9% 1.15 US$8,785
2013-03-14 2013-03-06 B Purchase Hemric Michael B. Non-Executive Director
4,998 +173.2%
1.14
US$5,698 		4,998 +173.2% 1.14 US$5,698
2012-08-16 2012-08-14 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
10,000 +inf%
1.15
US$11,500 		10,000 +inf% 1.15 US$11,500
2012-05-30 2012-05-23 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
7,000 -30.5%
0.95
US$6,650 		7,000 -30.5% 0.95 US$6,650
2012-05-30 2012-05-22 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
10,000 -38.6%
0.95
US$9,500 		10,000 -38.6% 0.95 US$9,500
2012-05-30 2012-05-21 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
907 -5.4%
1.00
US$907 		907 -5.4% 1.00 US$907
2012-05-30 2012-05-18 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
843 -5.0%
1.00
US$843 		843 -5.0% 1.00 US$843
2012-05-30 2012-05-17 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
300 -1.8%
1.02
US$306 		300 -1.8% 1.02 US$306
2012-05-30 2012-05-16 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
608 -3.7%
1.00
US$608 		608 -3.7% 1.00 US$608
2012-05-30 2012-05-15 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
1,485 -8.5%
1.00
US$1,485 		1,485 -8.5% 1.00 US$1,485
2012-05-30 2012-05-11 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
15 -0.1%
1.05
US$16 		15 -0.1% 1.05 US$16
2012-03-23 2012-03-19 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
8,500 -34.8%
1.15
US$9,775 		8,500 -34.8% 1.15 US$9,775
2012-03-07 2012-03-01 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
4,870 -23.4%
1.15
US$5,600 		4,870 -23.4% 1.15 US$5,600
2012-03-07 2012-02-28 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
130 -0.8%
1.15
US$150 		130 -0.8% 1.15 US$150
2011-05-13 2011-05-11 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
25,000 -61.1%
1.19
US$29,750 		25,000 -61.1% 1.19 US$29,750
2011-02-04 2011-01-27 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
5,000 -31.4%
1.75
US$8,750 		5,000 -31.4% 1.75 US$8,750
2010-12-08 2010-11-16 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
5,000 -31.4%
1.60
US$8,000 		5,000 -31.4% 1.60 US$8,000
2010-08-11 2010-08-10 B Purchase GERARDI FRANK Large shareholder
600 +0.0%
1.28
US$768 		600 +0.0% 1.28 US$768
2010-08-11 2010-08-10 B Purchase GERARDI FRANK Large shareholder
500 +0.0%
1.30
US$650 		500 +0.0% 1.30 US$650
2010-08-11 2010-08-09 B Purchase GERARDI FRANK Large shareholder
1,000 +0.0%
1.21
US$1,210 		1,000 +0.0% 1.21 US$1,210
2010-08-11 2010-08-09 B Purchase GERARDI FRANK Large shareholder
200 +0.0%
1.24
US$248 		200 +0.0% 1.24 US$248
Explore more

More insider trading research around Teligent Inc (NEW JERSEY)

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America